ST elevation without cardio-pulmonary symptoms  by Shah, Priyank et al.
Contents lists available at ScienceDirectJournal of Arrhythmia
Journal of Arrhythmia 32 (2016) 239–240http://d
1880-42
(http://c
n Corr
E-m
drrahulv
1 Tejournal homepage: www.elsevier.com/locate/joaECG for Students and Associated ProfessionalsST elevation without cardio-pulmonary symptomsPriyank Shah, MDa,1, Rahul Vasudev, MDb,n, Fayez Shamoon, MD, FACC, FSCAIc
a Department of Cardiology, St. Joseph’s Regional Medical Center, 1-D Donald Street, Bloomﬁeld, NJ 07003, USA
b Department of Internal Medicine, St. Joseph’s Regional Medical Center, 215 Overmount Avenue, Woodland Park, NJ 07424, USA
c Department of Cardiology, Trinitas Regional Medical Center, USAa r t i c l e i n f o
Article history:
Received 8 December 2015
Received in revised form
10 January 2016
Accepted 1 February 2016
Available online 17 March 2016
Keywords:
Burgada Syndrome
ST elevation
Myocardial infarction1. Case description
A 57-year-old man with no signiﬁcant past medical history
presented to the emergency department (ED) with complaints of
dysuria, increased frequency of urination, and subjective fevers
since 2 days. The patient denied any other symptoms. He did not
have any chest pain, dyspnea, orthopnea, paroxysmal nocturnal
dyspnea, dizziness, or palpitations. At the time of presentation, the
patient did not have a history of syncope or seizures. He worked in
construction and could tolerate exercise without dyspnea. He had
no family history of arrhythmias, sudden cardiac death, or cor-
onary artery disease. He smoked 20 cigarettes daily and had no
history of alcohol or illicit drug use. Vital signs on presentation
were as follows: temperature, 103 F (39.4 °C); blood pressure, 132/
80 mmHg; pulse, 116/min; and respiratory rate, 17/min. Oxygen
saturation was 100% on room air. Physical examination revealed
mild suprapubic tenderness, without any guarding or rigidity. His
cardiovascular examination revealed normal heart sounds, and
regular rate and rhythm, without any murmurs, rubs, or gallops.
There was no jugular venous distention, and the lungs were clear
to auscultation bilaterally. He underwent electrocardiography
(ECG) in the ED (Fig. 1). What would be the next most appropriate
step in the management of this patient?x.doi.org/10.1016/j.joa.2016.01.008
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(STEMI).
– Genetic testing and electrophysiology study (EPS) after infection
resolves.
– Schedule for Implantable Cardioverter Deﬁbrillator (ICD) once
infection resolves.
– Observation with outpatient follow-up after prompt treatment
of fever with antipyretics for urinary tract infection (UTI).2. Discussion
The answer is D. This patient had a typical Brugada type 1 ECG
pattern. Coved ST-segment elevation of more than or equal to
2 mm in at least either lead V1 or V2 with T-wave inversion is
considered typical type 1 pattern; this was not STEMI, and hence,
option 1 is incorrect. As per the 2015 European Society of Cardi-
ology (ESC) guidelines, prompt treatment of fever with antipyretic
drugs is a class I recommendation [1]. The most likely precipitating
factor in this patient was the high fever. The loss of sodium
channel current (INa) with an unopposed action of transient out-
ward current (Ito) is thought to be responsible for the ECG pattern
and risk for ventricular arrhythmias [2]. A rise in temperature
beyond the physiological range dramatically reduces the charge
carried by the sodium channel current (INa) and hence can lead to
its accelerated inactivation (premature closing). There can also be
a failure of the channel to express at higher temperatures [2].
Hence, these patients should be treated promptly with antipyretic
drugs. Since this patient had no history or syncope, seizures, or
family history of sudden cardiac death, he cannot be classiﬁed asopen access article under the CC BY-NC-ND license
Fig. 1. Results of ECG performed in the emergency room.
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having Brugada type 1 ECG pattern. This distinction is important,
as it will affect the management algorithm. The most common
genetic abnormality is a mutation in the SCN5A gene. Genetic
abnormalities exist in only one-third of Brugada Syndrome
patients [3]. Genetic testing is recommended for patients when
there is a clinical index of suspicion for Brugada Syndrome based
on clinical history, family history, and expressed ECG phenotype.
It is recommended that family members and appropriate relatives
follow the identiﬁcation of the Brugada Syndrome causative
genetic mutation in the index case [4]. Hence, in this patient,
genetic testing is not indicated. The role of EPS is controversial in
Brugada Syndrome patients. Brugada et al. reported inducibility of
ventricular arrhythmias as an independent predictor of arrhythmic
events [5]. In the two subsequent large-scale registries – FINGER
France, Italy, Netherlands, GERmany and PRogrammed ELectrical
stimUlation preDictive value (PRELUDE), inducibility during EPS
did not predict arrhythmic events [6,7]. These are the two largest
registries, which provide the strongest evidence for the use of EPS
in asymptomatic patients. Based on the most recent HRS/EHRA/
APHRS recommendations, ICD is recommended in Brugada Syn-
drome patients who meet the following criteria: (i) survivors of
cardiac arrest (class I), (ii) documented spontaneous sustained
ventricular arrhythmia with or without syncope (class I), and (iii)
spontaneous diagnostic type 1 ECG who have syncope judged
likely to be caused by ventricular arrhythmias (class IIa). ICD is not
indicated in asymptomatic patients with Brugada ECG pattern
(class III) [8]. Since our patient was asymptomatic, there is no role
of ICD in this patient. He had transthoracic echocardiography
done, which revealed normal left ventricular ejection fraction of
60% and no structural or valvular abnormalities. He was on con-
tinuous telemonitoring for more than 24 h until discharge, and
there was no evidence of premature ventricular contractions,
atrioventricular blocks, left axis deviation, paroxysmal atrial
ﬁbrillation, or transient left bundle branch block, which are some
of the ﬁndings supportive of a diagnosis of Brugada Syndrome [8].
Hence, the next best management option for this patient is theprompt treatment of his fever with antipyretic drugs for his UTI
with outpatient follow-up. If the ECG pattern persisted after
complete resolution of fever, the patient may be reclassiﬁed as
having spontaneous Brugada Syndrome and then followed-up
regularly with a cardiologist. Even in spontaneous ECG type
1 pattern (Brugada Syndrome), the role of EPS is not well deﬁned,
and even if there is inducibility of ventricular arrhythmia, ICD
implantation is a class IIb recommendation [8].Conﬂict of interest
All authors declare no conﬂict of interest related to this study.References
[1] Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. ESC guidelines for the
management of patients with ventricular arrhythmias and the prevention of
sudden cardiac death. Eur Heart J 2015;36(41):2793–867. http://dx.doi.org/
10.1093/eurheartj/ehv316 (Epub 2015 Aug 29).
[2] Antzelevitch C, Brugada R. Fever and Brugada syndrome. PACE 2002;25:1537–9.
[3] Mizusawa Y, Wilde AA. Brugada syndrome. Circ Arrhythm Electrophysiol
2012;5:606–16.
[4] Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus state-
ment on the state of genetic testing for the channelopathies and cardiomyo-
pathies this document was developed as a partnership between the Heart
Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
Heart Rhythm 2011;8:1308–39.
[5] Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in
individuals with the electrocardiographic pattern of Brugada syndrome and no
previous cardiac arrest. Circulation 2003;108:3092–6.
[6] Probst V, Veltmann C, Eckardt L, et al. Long-term prognosis of patients diag-
nosed with Brugada syndrome: results from the FINGER Brugada Syndrome
Registry. Circulation 2010;121:635–43.
[7] Priori SG, Gasparini M, Napolitano C, et al. Risk stratiﬁcation in Brugada syn-
drome: results of the PRELUDE (Programmed Electrical stimUlation preDictive
valuE) registry. J Am Coll Cardiol 2012;59:37–45.
[8] Prior SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus state-
ment on the diagnosis and management of patients with inherited primary
arrhythmia syndromes. Heart Rhythm 2013;10:1932–63.
